SSC 2026 Guidelines now available — 129 adult & 61 pediatric recommendations View guidelines →
The complete evidence-based CLABSI prevention guide: CDC/NHSN definitions, insertion bundle, maintenance bundle, CHG bathing, antimicrobial strategies, surveillance, and Zero CLABSI implementation.
Central line-associated bloodstream infection (CLABSI) is one of the most consequential healthcare-associated infections (HAIs) in the United States. The CDC’s National Healthcare Safety Network (NHSN) estimates more than 30,000 CLABSI events occur annually in US hospitals, at an attributable cost of $46,000–$68,000 per event and a mortality rate of 12–25% in ICU settings.
The evidence is unambiguous: the vast majority of CLABSI events are preventable. The landmark Michigan Keystone Project (Pronovost et al., 2006) demonstrated that consistent implementation of a five-element insertion bundle reduced ICU CLABSI rates by 66% within 18 months, with median rates reaching zero at many institutions. Two decades of subsequent evidence confirm that near-elimination of CLABSI is an achievable goal.
This guide covers the complete CLABSI prevention framework: definitions and epidemiology, pathophysiology, the insertion and maintenance bundles, antimicrobial strategies, NHSN surveillance, and a step-by-step Zero CLABSI program implementation guide.
CLABSI (Central Line-Associated Bloodstream Infection) is defined by the CDC/NHSN as a primary laboratory-confirmed bloodstream infection in a patient who had a central line in place on the date of the event or the day before, and the bloodstream infection is not related to an infection at another body site.
These terms are often used interchangeably in clinical settings but have important definitional differences:
| Term | Definition | Use Case |
|---|---|---|
| CLABSI | Surveillance definition — presence of central line at or before BSI event; does not require proving the line as the source | Public health surveillance (NHSN); regulatory reporting; quality benchmarking |
| CRBSI (Catheter-Related BSI) | Clinical/microbiologic definition — requires proof of catheter as source (differential time-to-positivity, semiquantitative catheter culture, etc.) | Clinical research; individual patient diagnosis and treatment decisions |
For hospital quality programs and NHSN reporting, the CLABSI definition is used. For individual patient treatment decisions (e.g., whether to remove a catheter), the CRBSI framework guides clinical judgment.
A CLABSI event is confirmed by NHSN criteria when:
Understanding how organisms enter the bloodstream via catheter guides prevention strategy:
Route 1: Extraluminal migration from insertion site skin — Skin colonizing organisms (Staphylococcus aureus, coagulase-negative staphylococci, gram-negative rods) migrate along the external catheter surface into the vascular space. Primary route for early-onset CLABSI (within first 10 days of catheter insertion). Prevention: insertion bundle (CHG antisepsis, maximal sterile barrier), CHG-impregnated dressings.
Route 2: Intraluminal contamination from the hub — Organisms enter via the needleless connector or catheter hub during access events. Primary route for late-onset CLABSI (after day 10, especially for long-term CVADs). Prevention: maintenance bundle (scrub-the-hub protocol, needleless connector management).
Route 3: Hematogenous seeding — Organisms from a distant infection site (e.g., urinary tract, pneumonia, wound) seed the catheter surface. Less common route. Prevention: treating remote infections promptly; timely catheter removal when systemic infection is present.
Patient-level risk factors for CLABSI include:
Device-level risk factors:
The CLABSI insertion bundle consists of five evidence-based practices that must be performed together, consistently, at every central venous catheter insertion. Compliance is verified by a real-time observer using a checklist.
Perform hand hygiene using ABHR (alcohol-based hand rub) or soap and water immediately before any contact with the catheter, insertion site, or insertion equipment. Hand hygiene is the single most important infection prevention behavior in healthcare.
Compliance failure pattern: Hand hygiene is frequently observed to be omitted or performed inadequately when insertions occur under time pressure or with multiple distractions. Observer-enforced checklists improve compliance at this step.
MSB requires: sterile gloves, sterile gown, cap, surgical mask, and large sterile drape covering the patient from head to feet. MSB is required for all CVC, PICC, and tunneled catheter insertions regardless of clinical urgency (except true emergency resuscitation).
Evidence: Raad et al. (1994) demonstrated that MSB reduced CLABSI from 3.3 to 0.5 per 1000 catheter-days — a 7-fold reduction compared to sterile gloves and small drape alone. This remains one of the strongest single-element insertion bundle studies.
Cleanse the insertion site with >0.5% CHG in alcohol (standard preparation: 2% CHG / 70% isopropyl alcohol). Allow full contact time and drying before needle puncture.
Site selection for non-tunneled CVCs should be documented in the insertion note, with rationale if a site other than subclavian or IJ is used.
Every day, each central line must be assessed for continued clinical necessity. The question: “Is this catheter still required for the patient’s current care plan?”
The maintenance bundle addresses intraluminal contamination — the primary route for late-onset CLABSI — through disciplined hub management, dressing care, and daily assessment.
At every catheter access event:
Passive disinfection caps (alcohol-impregnated port protectors) are an evidence-supported alternative that provides passive disinfection between access events and reduces active scrub-the-hub noncompliance. When used, they should be changed per manufacturer recommendations (typically 7 days or at each access).
CHG-impregnated dressings (disc, gel, or sponge configurations) are applied at the insertion site beneath or incorporated into the transparent dressing. Meta-analyses demonstrate a 65–80% reduction in CLABSI rates with CHG-impregnated dressings compared to standard TSM dressings (Ullman et al., 2016 Cochrane review).
current clinical standard recommends CHG-impregnated dressings for all CVADs in patients ≥2 months of age unless contraindicated (CHG allergy, skin integrity compromised at site).
Daily bathing with 2% CHG-impregnated cloths or 4% CHG solution for eligible ICU patients reduces CLABSI by 23–36% (Climo et al., 2013, NEJM). CHG bathing is recommended by SHEA/IDSA (2022 update) as a standard preventive measure for adult ICU patients.
Contraindications: CHG allergy, open wounds over large body surface area, age <2 months (neonates).
For patients in whom standard bundle compliance does not achieve acceptable CLABSI rates, antimicrobial catheters and dressings are a second-line prevention strategy.
Per CDC and IDSA guidance, antimicrobial catheters are indicated when:
Types of antimicrobial catheters:
Accurate surveillance is the foundation of any CLABSI prevention program.
Collecting catheter-days: Count one catheter-day per patient per calendar day with a central line present, regardless of number of lines. Catheter-day denominators are collected by daily census or EHR data extraction.
Rate calculation: CLABSI events ÷ catheter-days × 1,000 = CLABSI rate per 1,000 catheter-days
NHSN reporting: Required monthly for all CMS-participating hospitals. Submit via NHSN Patient Safety Component — Device-Associated Module.
Standardized Infection Ratio (SIR): NHSN calculates a SIR comparing your observed CLABSI count to the predicted count based on your facility type and patient population. SIR <1.0 indicates better than predicted performance; SIR >1.0 indicates worse. CMS uses SIR for HACRP scoring.
See the CLABSI Prevention Implementation Framework for the complete printable checklist and step-by-step program launch guide. Key implementation steps:
Evidence-based guide to needleless connectors and CLABSI prevention: connector types (split-septum, mechanical valve), scrub-the-hub technique, change intervals, passive disinfection caps, and selecting connectors to minimize CLABSI risk.
Complete guide to the CLABSI maintenance bundle: scrub-the-hub technique, CHG-impregnated dressings, CHG daily bathing, needleless connector management, administration set change intervals, and daily necessity review and CDC guidelines.
Evidence-based guide to the CLABSI insertion bundle: 5 elements (hand hygiene, maximal sterile barrier, CHG antisepsis, optimal site selection, daily necessity review), implementation, and bundle compliance documentation.
Complete overview of CLABSI definition (NHSN criteria), epidemiology (incidence, mortality, cost), CLABSI vs CRBSI distinction, NHSN surveillance methodology, SIR benchmarking, and how CLABSI rates are calculated.
Evidence-based guide to chlorhexidine gluconate (CHG) in CLABSI prevention: skin antisepsis (2% CHG vs povidone-iodine), CHG-impregnated dressings, daily CHG bathing, application technique, dry time requirements, and CHG safety considerations.
Evidence-based guide to antimicrobial-impregnated catheters (CHG/SS, minocycline-rifampin), antimicrobial dressings, and antimicrobial lock therapy for CLABSI prevention in high-risk settings — indications, evidence, and limitations.